97 related articles for article (PubMed ID: 9863178)
1. Correlation between expression of mdr-1 gene and oncogenes in human promyelocytic leukemic HL60 cell line and sublines.
Zhou WD; Zhang HQ; Fang M; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):471-3. PubMed ID: 9863178
[TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptosis of harringtonine-resistant HL60 cells induced by tetrandrine.
He QY; Zhang HQ; Pang DB; Chi XS; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):545-9. PubMed ID: 9863153
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of harringtonine-resistant human leukemia HL60 cell.
He QY; Zhou WD; Ji L; Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):463-7. PubMed ID: 9863176
[TBL] [Abstract][Full Text] [Related]
4. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
Eliot HE; Borner MM; Sinha BK
Anticancer Res; 1995; 15(3):729-33. PubMed ID: 7645949
[TBL] [Abstract][Full Text] [Related]
5. Cellular models of drug- and radiation-resistant small cell lung cancer.
Davey RA; Locke VL; Henness S; Harvie RM; Davey MW
Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
[TBL] [Abstract][Full Text] [Related]
6. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
7. Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells.
Osmak M; Sorić J; Matulić M
Neoplasma; 1993; 40(6):359-62. PubMed ID: 8289968
[TBL] [Abstract][Full Text] [Related]
8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
9. Screening and cloning of multi-drug resistant genes in HL-60/MDR cells.
Zheng GH; Fu JR; Xu YH; Jin XQ; Liu WL; Zhou JF
Leuk Res; 2009 Aug; 33(8):1120-3. PubMed ID: 19135252
[TBL] [Abstract][Full Text] [Related]
10. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells.
Imaizumi M; Breitman TR
Cancer Res; 1988 Dec; 48(23):6733-8. PubMed ID: 3180083
[TBL] [Abstract][Full Text] [Related]
11. [Expression of glucosylceramide synthase mRNA in vincristine-resistant KBV200 cell line in association with multidrug resistance].
Yang Q; Zhang J; Wang SM; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):779-81. PubMed ID: 15257901
[TBL] [Abstract][Full Text] [Related]
12. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
[TBL] [Abstract][Full Text] [Related]
13. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224
[TBL] [Abstract][Full Text] [Related]
14. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
15. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
17. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
[TBL] [Abstract][Full Text] [Related]
18. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor c-Jun activation represses mdr-1 gene expression.
Miao ZH; Ding J
Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
[TBL] [Abstract][Full Text] [Related]
20. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]